Legislative & Licensing Update: May 12, 2022
May 12, 2022
May 12, 2022
Double Required Signatures Delivered in Missouri
Plus: More NewYork conditional cultivation licenses, House passage in Deleware, a stall out in Kansas, advertising rules filed in Mississippi, and more news from Vermont, Illinois, Texas, Colorado, and Canada.
The federal government is promoting funding opportunities for researchers to study the benefits and risks of marijuana for cancer patients.
Vermont House and Senate negotiators are set to debate marijuana potency limits in a conference committee.
New York regulators Approved 32 More conditional cannabis cultivator licenses as the state prepares to launch retail sales ‘this year’.
The Delaware House approved a cannabis legalization bill, sending it to the Senate.
Mississippi regulators filed medical cannabis advertising rules.
The Illinois Department of Financial and Professional Regulation reported that retailers sold nearly $132 million worth of legal recreational marijuana products in April—the second-highest monthly adult-use cannabis sales total since legalization began.
Missouri activists turned in what they say are double the amount of signatures they need to qualify a marijuana legalization initiative for the November ballot.
A Kansas Senate leadership spokesperson said it is “unlikely” lawmakers will pass a medical cannabis bill when they return to session later this month.
Colorado Governor Jared Polis is backing psychedelics reform and says prohibition inhibits research into their medical benefits.
Austin, Texas voters approve a local marijuana decriminalization ballot initiative.
Working in Canada’s cannabis industry does not make people inadmissible to U.S., border patrol.